How Fresenius can become future-proof again

The good years are over for Merck

How the new CEO Bayer has to move forward

How the new CEO Bayer has to move forward

Eleven European stocks with high potential

Swiss equities are considered a safe haven

Swiss equities are considered a safe haven

Seven funds with which they invest in the healthcare industry